This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


John (Jay) Daly
Clinical Study Risk Manager, Clinical Data Operations, Technology and Standards at UCB Biopharma


Over his career, Jay Daly has gained almost 20 years of experience in clinical monitoring, project management, quality assurance, and risk based monitoring. He has worked within the Biopharmaceutical and CRO environments in global trials, across multiple therapeutic areas and phases of product development. Jay joined the Risk Management and Data Quality Department at UCB as a Study Data Risk Manager in 2017 and transitioned into the role of a Risk Management Lead in 2019. He is responsible for facilitating risk assessment and planning activities, which include performing protocol complexity assessments, identifying critical data and processes, establishing quality tolerance limits, and managing the risk registry.

Agenda Sessions

  • Case Study: New Technologies and Their Approach to RBM at UCB

  • Panel Discussion: Innovative Approaches to Remote Monitoring During and Post - COVID-19